S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

CenterGate Capital Acquires Stake in Canadian Dental Labs

Austin-based private equity firm CenterGate Capital has acquired a stake in Canadian Dental Labs, the country’s largest manufacturer of dental prosthetics and orthodontic appliances. The Toronto-headquartered company manages a network of eleven laboratories, serving over 5,000 independent dental practitioners and service organizations across the Canadian provinces.

CenterGate Capital Acquires Stake in Canadian Dental Labs
Photo: Bio & News

CEO Ali Rezaei will remain at the helm of CDL as the company transitions into its next growth phase. The organization currently oversees a diverse portfolio of premium laboratory groups, including Shaw Lab Group in Ontario, Protec Dental in British Columbia, Hallmark Dental in Atlantic Canada, and Universal Dental in Alberta. Rezaei noted that the partnership aims to accelerate investments in personnel, advanced technology, and facility infrastructure to maintain current service standards.

Steele Windle, Managing Director at CenterGate Capital, highlighted CDL’s technical excellence and market position as primary drivers for the investment. The firm, which manages over $750 million in assets, focuses on scaling middle-market companies through a combination of operational support and capital infusion. Legal representation for CenterGate was provided by Akerman LLP and Blake, Cassels & Graydon LLP, while BMO Middle Market M&A and ATB Cormark Capital Markets acted as financial advisors to CDL.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!